Irregular Global Use of Patient Reported Outcomes - Presented at ISPOR 2012

Our recent global analysis of product evaluations for Health Technology Assessments  – which are often influential in decision making for approving and/or providing reimbursement for pharmaceuticals and other medical technology – found that the use of patient-reported outcomes (PROs) increased  between 2005 and 2011. The study also showed substantial variation across both nations and treatment areas in applying HTAs to such decisions. Click here for more information